Details of the Drug

General Information of Drug (ID: DMU5OLF)

Drug Name

GS030

Indication

Disease Entry	ICD 11	Status	REF
Retinitis pigmentosa	9B70	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Gene therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03326336) A Phase 1/2a, Open-Label, Non-Randomized, Dose-Escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa. U.S.National Institutes of Health.